Polaris Venture Management Co. V as of March 31, 2021
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 8 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics Common Stock (FATE) | 60.9 | $47M | 570k | 82.45 | |
| Lyra Therapeutics Common Stock (LYRA) | 16.5 | $13M | 1.1M | 11.59 | |
| Selecta Biosciences Common Stock | 16.3 | $13M | 2.8M | 4.53 | |
| x4 Pharmaceuticals Common Stock (XFOR) | 3.5 | $2.7M | 312k | 8.61 | |
| Atyr Pharma Common Stock | 0.8 | $581k | 131k | 4.45 | |
| Dare Bioscience Common Stock | 0.7 | $551k | 326k | 1.69 | |
| Genocea Biosciences Common Stock (GNCAQ) | 0.7 | $535k | 197k | 2.71 | |
| Pulmatrix Common Stock | 0.6 | $478k | 359k | 1.33 |
